US Pharmacopeia announces revised heparin monographs and reference...(f heparin. The expedited revision o...),Health
f heparin.
"The expedited revision of USP's heparin standards gives manufacturers, health care practitioners and patients increased confidence that this widely used drug is free of this adulterant," said Roger L. Williams, M.D., USP executive vice president and CEO. "The monograph revisions were completed quickly to alleviate a major public health concern; they were accomplished through USP's established, transparent, and scientific process. In updating the standards, USP received guidance not only from the FDA but also from the volunteer experts on USP's Heparin Advisory Panel and USP's Blood and Blood Products Expert Committee, which concluded the monograph standards, and USP's Reference Standards Committee, which endorsed the physical standards. USP thanks these colleagues and the many other national and international experts who assisted the USP Council of Experts' Expert Committees and Advisory Panel and worked with us to meet this extremely important challenge."
USP publishes official quality standards for medicines in the United States PharmacopeiaNational Formulary (USPNF) and has worked with FDA for more than 100 years in a unique public-private partnership that helps to assure the quality of medicines in the United States. The availability of a good public monograph in the USPNF along with allied reference materials is one of a series of safety nets that help assure that U.S. patients and practitioners have access to good quality medicines.
"While USP monographs are generally designed to test for known impurities that may result from the manufacturing process or degradation, and not for unknown contaminants that may be added either accidentally or deliberately, we were pleased to modify our standards to help alleviate patient danger associated with the heparin product and will continue to explore methods for detecting potential contaminants," Dr. Williams noted.
'/>"/>
| Contact: Laura Provan lnp@usp.org 301-816-8268 US Pharmacopeia Source:Eurekalert |
Related medicine news :
1. U.S. Pharmacopeia Aiding FDA in Improved Tests for Heparin Contamination
2. U.S. Pharmacopeia Releases New Edition of the Food Chemicals Codex
3. US Pharmacopeia releases new edition of the Food Chemicals Codex
4. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
5. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
6. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
7. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
8. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
11. Pharmacopeia Announces Senior Additions to Management Team
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |